2.39
+0.035(+1.49%)
Currency In USD
| Previous Close | 2.35 |
| Open | 2.38 |
| Day High | 2.43 |
| Day Low | 2.3 |
| 52-Week High | 10.16 |
| 52-Week Low | 2.08 |
| Volume | 19,615 |
| Average Volume | 93,104 |
| Market Cap | 6.84M |
| PE | -1.55 |
| EPS | -1.54 |
| Moving Average 50 Days | 2.59 |
| Moving Average 200 Days | 3.31 |
| Change | 0.04 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $259.24 as of December 19, 2025 at a share price of $2.385. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $58.11 as of December 19, 2025 at a share price of $2.385.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
GlobeNewswire Inc.
Dec 11, 2025 1:08 PM GMT
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection • Designed for early detection
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
GlobeNewswire Inc.
Nov 25, 2025 1:19 PM GMT
Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
GlobeNewswire Inc.
Nov 06, 2025 1:19 PM GMT
Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica’s updated website IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BM